DAXXIFY Revance Australia Pty Ltd
Product name
DAXXIFY
Sponsor
Accepted date
Nov-2023
Active ingredients
daxibotulinumtoxinA
Proposed indication
DAXXIFY is indicated for the temporary improvement in the appearance of moderate to severe
glabellar lines.
glabellar lines.
Application type
A (new medicine)
Publication date
Nov-2023